Of note, while Osteopontin appears to be a cancer biomarker for 31 individual malignancies its levels were significantly reduced below normal in non-melanoma skin cancer and gestational trophoblastic tumor. This evidence concerns the gene SPP1 and gestational trophoblastic neoplasm.